Glasgow III-V Semiconductor Epitaxial Growth Facility
The Glasgow Epitaxy Facility (GEF) supports academic and industrial research in III-V semiconductor materials and devices, accelerating the development of next-generation photonic and electronic technologies.
We provide high-quality, customisable MOCVD & MBE growth services for GaAs- and InP-based materials to academic and commercial partners, at low-to-medium volume. We also provide design and analytical services, as well as training to support partners to drive innovations that address critical technological challenges.
The GEF is the only facility in Scotland capable of delivering bespoke base epitaxy and regrowth services, fulfilling a crucial role within the critical technologies ecosystem of the Scottish Central Belt.
Growth Capability:
|
Technique |
Substrate |
Group-III |
Group-V |
Dopants |
|
MOCVD (3x2” CCS) |
GaAs / InP / Si 2” / 3” / 4” |
TMAl TMGa TMIn |
PH3 AsH3 TESb |
Si2H6 DMZn CBr4 Fe(C2H5)2 |
|
MBE |
GaAs / InP / Si 2” / 3” / 4” |
Al Ga In |
P As Sb |
Si Te Be |
Characterisation Capability:
|
Structure |
Doping |
Morphology |
|
PL – wafer mapping PL – low temperature XRD – ω-2ϑ, RSM *(S)TEM |
ECV Hall Effect *SIMS |
Optical Microscopy SEM AFM |
|
* Analytical services provided by external partner |
||
Management Team:
The GEF team have more than 75 years of combined experience in III-V materials design and growth.
Prof Stephen Sweeney - Academic Lead
Prof Jeff Kettle - Academic Co-Lead
Dr Adam McKenzie - Research Fellow (MOVPE Specialist)
Dr Neil Gerrard - Industrials Epitaxy Consultant
Access:
To discuss facility access and partnership on academic or commercial projects, please contact Prof. Stephen Sweeney or Dr Adam McKenzie.
Where appropriate, we may direct you to our commercial delivery partner, III-V Epi Ltd.
Research Interest:
N-IR (780 – 2500 nm) light sources
Regrowth of nanostructured lasers, such as DFBs and PCSELs
III-V on Si and selective epitaxy for photonic integration
Novel Sb-containing active structures
GaAs-based photovoltaics
Our Partners:
